Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc.

OVID | NASDAQ
Chart Builder DCF Calculator
$2.71
+$0.02 (+0.74%)
At close: Sep 21, 2026, 4:00 PM ET
$2.71
$0 (0.00%)
Pre-market: Sep 22, 2026, 8:22 AM ET

Market Data

Market Cap
$505.79M
Enterprise Value
$401.29M
Beta
0.25
Average Volume
2.11M
Shares Outstanding (Diluted)
197.45M
Shares Change YoY
177.67%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US6904691010

Price Performance

Price Change 1M
-1.4%
Price Change 3M
16.8%
Price Change 6M
12.9%
Price Change YTD
54.0%
Price Change 1Y
110.1%
Price Change 3Y
-25.6%
Price Change 5Y
-21.4%
1M CAGR (ann.)
3.0%
1Y CAGR (ann.)
122.1%
5Y CAGR (ann.)
-4.9%
All-Time CAGR
-14.8%

Valuation

PE Ratio
-7.53
Forward PE
N/A
PEG Ratio
0.16
Forward PEG
-0.57
PS Ratio
319.52
Forward PS
1,585.60
PB Ratio
2.41
P/FCF Ratio
-9.23
P/Adj. FCF Ratio
-8.81
P/OCF Ratio
-3.66
EV/Sales
253.50
EV/EBIT
-11.19
EV/EBITDA
-11.21
EV/FCF
-7.33
Earnings Yield
-13.3%
FCF Yield
-10.8%
Adj. FCF Yield
-11.3%

Financial Health

Net Cash
$117.22M
Total Debt
$12.72M
Cash & Short-Term Investments
$117.22M
Total Assets
$231.97M
Current Ratio
12.39
Quick Ratio
12.39
Debt / Equity Ratio
0.06
Debt / EBITDA
-0.36
Debt / FCF
-0.23
OCF / Debt
-4.31
Interest Coverage
0.00
Altman Z-Score
11.69
Piotroski F-Score
2

Margins & Profitability

Gross Profit Margin
100.0%
Operating Profit Margin
-3686.7%
EBITDA Margin
-2252.4%
Net Profit Margin
-2178.9%
FCF Margin
-3460.1%
Adj. FCF Margin
-3626.0%
SBC / Revenue
165.9%
SBC Impact (per share)
-4.8%

Returns

Return on Assets
-14.9%
Return on Equity
-23.6%
Return on Invested Capital
-26.1%
Return on Capital Employed
-26.3%
Return on Tangible Assets
-14.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
99.8%
Revenue CAGR 5Y
-62.8%
Revenue CAGR 10Y
-4.1%
EPS CAGR 3Y
7.9%
EPS CAGR 5Y
23.4%
EPS CAGR 10Y
24.3%
FCF CAGR 3Y
-1.8%
FCF CAGR 5Y
2.3%
FCF CAGR 10Y
-8.6%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
14
EPS Growth Next 3Y
-2.8%
Revenue Growth Next 3Y
90.2%
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.08
EPS Growth Est (next Q)
-52.9%
Revenue Est (next Q)
$17.75K
Revenue Growth Est (next Q)
-86.5%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6.50
Price Target Upside
139.9%

Cash Flow

Operating Cash Flow
$-54.77M
Free Cash Flow
$-54.77M
Adj. Free Cash Flow
$-57.4M
FCF Per Share
-$0.74
OCF Per Share
-$0.74
OCF/S Ratio
-3460.1%

Income Statement

Revenue
$1.58M
Gross Profit
$1.55M
Operating Income
$-58.36M
EBITDA
$-35.8M
Net Income
$-34.49M
EPS (Diluted)
-$0.36
Revenue / Employee
$68.83K
Profit / Employee
$-1.5M
Employees
23

© 2026 bestshares.com. All rights reserved.